BAFNA PHARMACEUTICALS LTD.

NSE : BAFNAPHBSE : 532989ISIN CODE : INE878I01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE86.94-1.06 (-1.2 %)
PREV CLOSE ( ) 88.00
OPEN PRICE ( ) 87.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 191
TODAY'S LOW / HIGH ( )86.94 87.00
52 WK LOW / HIGH ( )76.5 125.55
NSE86.850.35 (+0.4 %)
PREV CLOSE( ) 86.50
OPEN PRICE ( ) 88.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 12235
TODAY'S LOW / HIGH( ) 85.00 88.70
52 WK LOW / HIGH ( )75.9 124.45
( in Million)
Select year
ParticularsMar2020Mar2019Mar2018Mar2017Mar2016
Profit Before Tax-18.83-182.93-147.17-203.63-153.19
Adjustment-194.5254.48-195.26155.02158.36
Changes In working Capital-129.73110.58271.9639.133.94
Cash Flow after changes in Working Capital-343.09-17.87-70.47-9.479.11
Cash Flow from Operating Activities-343.09-17.87-70.47-9.479.11
Cash Flow from Investing Activities327.75153.62379.70-54.20-3.62
Cash Flow from Financing Activities73.01-138.13-306.2963.11-6.05
Net Cash Inflow / Outflow57.68-2.382.93-0.56-0.56
Opening Cash & Cash Equivalents27.1329.5126.5827.1427.70
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange FluctuationsNANANANANA
Closing Cash & Cash Equivalent84.8127.1329.5126.5827.14

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.